Psychiatry & Psychotherapy Podcast Long-Acting Injectables with Dr. Cummings
18 snips
Jan 10, 2023 Dr. Michael Cummings, a key figure in California's drug formulary, discusses long-acting injectable antipsychotics (LAIs). He highlights their advantages in improving patient adherence and significantly reducing relapse rates. The conversation covers the transition from oral medications, the importance of individualized dosing, and safety protocols. Cummings also addresses metabolic impacts and weight management strategies, ensuring a comprehensive look at how LAIs enhance psychiatric care. The discussion advocates for better treatment accessibility, particularly for underserved populations.
AI Snips
Chapters
Transcript
Episode notes
LAIs Improve Adherence and Outcomes
- Long-acting injectables (LAIs) should be the preferred antipsychotic form due to better adherence and lower relapse rates.
- In Europe, 60% use LAIs, while in the US usage is only 10%, which is suboptimal for patients' outcomes.
LAIs Reduce Mortality by 30%
- People taking long-acting injectable antipsychotics have a 30% lower risk of all-cause mortality than those on oral forms.
- This impressive effect includes reduced deaths from suicide, accidents, and violence.
Learn Injection Techniques from Nurses
- Psychiatrists unfamiliar with injections should learn from experienced nurses how to give intramuscular injections.
- Injection techniques differ by drug vehicle, such as saline-based and oil-based requiring z-tracking to avoid leakage.